Works matching IS 1007385X AND DT 2022 AND VI 29 AND IP 7

Results: 13

EGFR 复杂突变对酪氨酸激酶抑制剂治疗非小细胞肺癌疗效影响的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 692, doi. 10.3872/j.issn.1007-385x.2022.07.013

By:

付于卉;
姜达

Publication type:

Article

靶向 CD70 抗肿瘤药物的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 686, doi. 10.3872/j.issn.1007-385x.2022.07.012

By:

杨凡;
纪锋;
郭志刚

Publication type:

Article

CLDN18.2 在消化系统恶性肿瘤中作用的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 681, doi. 10.3872/j.issn.1007-385x.2022.07.011

By:

王俏丽;
杜娟

Publication type:

Article

头颈部鳞状细胞癌的肿瘤微环境及免疫治疗研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 671, doi. 10.3872/j.issn.1007-385x.2022.07.010

By:

刘华联;
蒋敬庭

Publication type:

Article

微生物在食管癌发生发展和治疗中作用及机制的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 665, doi. 10.3872/j.issn.1007-385x.2022.07.009

By:

刘彦君;
左静

Publication type:

Article

患者肿瘤组织来源的胶质母细胞瘤类器官的制备方法.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 659, doi. 10.3872/j.issn.1007-385x.2022.07.008

By:

赖名耀;
李少群;
李新晨;
邵媛;
郁洁;
李海南;
李娟;
胡清军;
周江芬;
艾茹玉;
周兆明;
林涛;
金鑫;
穆林森;
欧阳辉;
鲁明;
范晓虎;
蔡林波

Publication type:

Article

基于 Citespace 的可视化分析 STING 信号通路在乳腺癌进展中的作用.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 653, doi. 10.3872/j.issn.1007-385x.2022.07.007

By:

卢钟琦;
付强;
金铁峰;
张美花

Publication type:

Article

一线晚期肺腺癌治疗中 PD-1 抗体联合化疗和抗血管生成药物联合化疗的对比研究.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 646, doi. 10.3872/j.issn.1007-385x.2022.07.006

By:

段玉青;
夏宁;
贾云泷;
吕微;
王郁;
王佳丽;
王雪晓;
刘天旭;
刘丽华

Publication type:

Article

miR-1243 通过靶向 hnRNPA2B1 调控肝癌 HepG2 细胞增殖和迁移.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 639, doi. 10.3872/j.issn.1007-385x.2022.07.005

By:

韩建涛;
谢兴旺

Publication type:

Article

lncRNA SUMO1P3 诱导肝癌 HepG2 细胞对索拉菲尼耐药的分子机制.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 631, doi. 10.3872/j.issn.1007-385x.2022.07.004

By:

张生;
熊万成;
苗志钊;
周兵

Publication type:

Article

CD19 和 CD22 双靶点 CAR-T 细胞对肿瘤细胞的杀伤作用.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 623, doi. 10.3872/j.issn.1007-385x.2022.07.003

By:

李薇;
曾伟杰;
彭浩;
刘灿;
刘广花;
肖非笛;
曾桂芳;
梁晓;
蔡车国;
胡隽源;
周明

Publication type:

Article

基于肠道微生物的肿瘤发生机制及其治疗策略.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 613, doi. 10.3872/j.issn.1007-385x.2022.07.002

By:

郑开文;
崔久嵬;
李薇

Publication type:

Article

基于 mRNA-LNP 的肿瘤免疫疗法.

Published in:

Chinese Journal of Cancer Biotherapy, 2022, v. 29, n. 7, p. 605, doi. 10.3872/j.issn.1007-385x.2022.07.001

By:

曹学智;
彭华;
傅阳心

Publication type:

Article